The heart failure pandemic: The clinical and economic burden in Greece
| Autor: | Nikolaos Maniadakis, P Stafylas, K. Tsarouhas, Georgia Kourlaba, Gregory Giamouzis, Dimitrios Farmakis, John Parissis |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty National Health Programs Pilot Projects Disease 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Cost of Illness Surveys and Questionnaires Health care Epidemiology Pandemic medicine Humans 030212 general & internal medicine Prospective Studies Disease management (health) Intensive care medicine Pandemics Aged Aged 80 and over Heart Failure Greece business.industry Mortality rate Middle Aged Hospitalization Emergency medicine Economic evaluation Observational study Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | International journal of cardiology. 227 |
| ISSN: | 1874-1754 |
| Popis: | The objective of this study was to identify the epidemiological and clinical characteristics of heart failure (HF) patients in Greece as well as the economic burden and the distribution of costs for the management of the disease.Eight Greek secondary and tertiary cardiology centres from different cities have participated in a prospective, observational survey, the ESC HF Pilot Survey. 307 patients with HF, 177 hospitalised and 130 outpatients, have been recruited and monitored for 12months. Clinical and epidemiological data, along with data on mortality, hospitalisations and health care resources used have been collected. The economic evaluation was conducted from the social security system perspective.The annual mortality rate was 24.3% for the hospitalised patients vs 7.7% for the outpatients (P0.001) and the annual rehospitalisation rate was 42.9% vs 19.2% respectively (P0.001). Kaplan-Meier analyses revealed that patients with kidney dysfunction, S3 gallop and higher NYHA class have a significantly worse survival. The mean annual economic burden of the social security system per HF patient was estimated at €4411±4764. About two thirds of this cost is due to in-patient care.Despite the progress in the management of the disease, about one in four hospitalised patients dies and four in ten are rehospitalised in less than one year. Moreover, the disease imposes a significant economic burden for the social security system and national economy. Their findings suggest that there is still need of more effective drug treatment and efficient disease management programs focused in the reduction of the hospital admissions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect